Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
3 Stocks to Buy and Hold for 2026 and Beyond
12:15pm, Thursday, 19'th Feb 2026
AbbVie is a Dividend King, poised for strong growth with Rinvoq and Skyrizi. Eli Lilly has taken control of the obesity drug market, with major possibilities ahead.
AbbVie Declares Quarterly Dividend
09:37am, Thursday, 19'th Feb 2026
NORTH CHICAGO, Ill., Feb. 19, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.
2 Dividend Stocks to Hold for the Next 5 Years
03:45am, Thursday, 19'th Feb 2026
AbbVie is a Dividend King that's a successful player in multiple critical therapeutic areas. Enbridge is an energy infrastructure leader with an especially attractive dividend.
6 Forever Dividend Stocks
10:37am, Wednesday, 18'th Feb 2026
Cash Flowing Companies that Raise Dividends
The Zacks Analyst Blog AbbVie, RTX, International Business Machines, EVI Industries, and Rocky Mountain Chocolate Factory
04:10am, Wednesday, 18'th Feb 2026
AbbVie, RTX and IBM headline Zacks??? top analyst picks after strong earnings beats and solid backlog, cloud and AI-driven momentum.
AbbVie Down Since Q4 Earnings Report: How to Play the Stock
10:01am, Tuesday, 17'th Feb 2026
ABBV stock declines since it announced earnings results on Feb. 4. Skyrizi and Rinvoq fuel growth, offsetting Humira erosion.
AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus
07:13am, Tuesday, 17'th Feb 2026
Executives from AbbVie (NYSE: ABBV) outlined upcoming clinical milestones and development priorities across hidradenitis suppurativa (HS), inflammatory bowel disease (IBD), and several earlier-stage i
Cardano Risk Management B.V. Boosts Stake in AbbVie Inc. $ABBV
06:00am, Tuesday, 17'th Feb 2026
Cardano Risk Management B.V. grew its position in shares of AbbVie Inc. (NYSE: ABBV) by 2.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
AbbVie Inc. $ABBV Shares Purchased by Merit Financial Group LLC
05:20am, Tuesday, 17'th Feb 2026
Merit Financial Group LLC raised its position in AbbVie Inc. (NYSE: ABBV) by 3.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (
AbbVie: Dominating Immunology While Building Oncology Upside
01:11am, Tuesday, 17'th Feb 2026
None of the Big Pharma players has succeeded in challenging AbbVie's dominance in the immune-mediated inflammatory diseases market. In my view, this is directly related to the near-perfect complementa
Why AbbVie (ABBV) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 16'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AbbVie Inc. $ABBV Shares Acquired by Fifth Third Bancorp
04:28am, Monday, 16'th Feb 2026
Fifth Third Bancorp increased its position in shares of AbbVie Inc. (NYSE: ABBV) by 1.7% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commissi
1 No-Brainer Dividend Stock to Buy on the Dip
05:05pm, Sunday, 15'th Feb 2026
AbbVie's shares dropped after its recent earnings report. Despite a potential issue, the company's outlook seems strong.
3 Dividend Stocks to Hold for the Next 20 Years
04:47am, Sunday, 15'th Feb 2026
AbbVie has demonstrated its ability to successfully navigate change. Coca-Cola will likely soon increase its dividend for the 64th consecutive year.
Assetmark Inc. Increases Stock Position in AbbVie Inc. $ABBV
04:43am, Sunday, 15'th Feb 2026
Assetmark Inc. increased its holdings in AbbVie Inc. (NYSE: ABBV) by 4.9% in the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 105,319 shares of
